已收盘 05-08 16:00:00 美东时间
+0.700
+1.24%
Innovative Ind Props (NYSE:IIPR) held its first-quarter earnings conference cal...
05-06 00:39
Innovative Industrial Properties shares are trading higher after the company re...
05-05 23:32
Innovative Ind Props (NYSE:IIPR) reported quarterly earnings of $1.88 per share which beat the analyst consensus estimate of $1.79 by 5.03 percent. This is a 3.09 percent decrease over earnings of $1.94 per share from
05-05 04:31
Companies Reporting Before The Bell • Pulse Biosciences (NASDAQ:PLSE) is likely...
05-04 19:11
Innovative Industrial Properties updates financial calendar for quarterly results and conference call Innovative Industrial Properties schedules Q1 fiscal 2026 earnings release for May 4, 2026. Investor conference call set for May 5, 2026 at 9:00 a.m. Pacific Time. Live webcast will stream via Inves
04-20 18:30
BRIEF-Innovative Industrial Properties Announces Pharmacann Resolution And Provides Portfolio Update March 16 (Reuters) - Innovative Industrial Properties Inc IIPR.N : INNOVATIVE INDUSTRIAL PROPERTIES ANNOUNCES PHARMACANN RESOLUTION AND PROVIDES PORTFOLIO UPDATE INNOVATIVE INDUSTRIAL PROPERTIES INC
03-16 18:40
IIP resolves PharmaCann lease-default litigation with monetary judgments and property turnover orders Innovative Industrial Properties said it resolved all pending litigation with PharmaCann related to prior lease defaults. The settlement includes monetary judgments for amounts owed under leases tie
03-16 18:30
Innovative Industrial Properties declares Q1 2026 dividend of USD 1.9 per share Innovative Industrial Properties declared a first-quarter 2026 dividend of 1.9 per common share, representing an annualized dividend of 7.6 per common share. The company also declared a regular quarterly dividend of 0.56
03-13 17:31
Innovative Industrial Properties declares Q1 2026 dividend of USD 1.90 per share Innovative Industrial Properties said its board declared a first-quarter 2026 dividend of USD 1.90 per common share. The company said the dividend is payable on April 15, 2026 to stockholders of record as of March 31, 2
03-13 17:30
今日重点评级关注:HC Wainwright & Co.:维持NRX Pharmaceuticals"买入"评级,目标价从40美元升至45美元;RBC Capital:维持NUVATION BIO"跑赢大市"评级,目标价从12美元升至13美元
03-04 10:22